Skip to main content
. 2023 Feb 6;28(4):351–357. doi: 10.1093/oncolo/oyac266

Table 3.

Self-reported factors that influenced patient decisions.

Accepted adjuvant nivolumab, n = 12 Observation,n = 17 P-value
Perceived physician recommendation 12 (100%) 11 (64.7%) .028
Speaking with family/loved ones 10 (83.3%) 13 (76.4%) 1.0
Informational video 10 (83.3%) 13 (76.4%) 1.0
Personal reasons 11 (91.7%) 15 (88.2%) 1.0

Data from 5 patients were missing due to patient withdrawal from study (2), patient failed to complete the month 3 questionnaire (2), or patient died (1).